What is Longeveron LLC?
, a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States. Its lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors which is in phase 3 clinical trial to treat hypoplastic left heart syndrome; completed phase 2a clinical trial to treat Alzheimer's disease, as well as in phase 2b clinical trial to treat aging frailty. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 5.60M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.